Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Monkeypox Virus D13L Protein (MPXV D13L), N-His

Cat. No.VG3F91

Product TypeVeterinary Antigens

Size

Product Overview

BioVenic's Recombinant Monkeypox Virus D13L Protein (MPXV D13L), N-His is a recombinant protein expressed from E.coli Expression System. Its predicted molecular weight is 39.4 kDa. The purity is>90% (SDS-PAGE).

Specifications

Type Recombinant Protein
Species Virus
Expression System E.coli Expression System
Purity >90% (SDS-PAGE)
Predicted Molecular Weight 39.4 kDa
Physical State Lyophilized
Formulation PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Target Information

D13L is a critical structural protein that forms a transient hexagonal scaffold on the exterior of the developing viral membrane. This scaffold is essential for transforming flat lipid membranes into the spherical "crescent" structures required for Intracellular Mature Virus (IMV) assembly. As the major target of the antiviral drug Rifampicin, D13L is indispensable for viral morphogenesis. Without functional D13L, the virus cannot form infectious progeny. Its unique structural role makes it a high-priority target for small-molecule inhibitors and structural studies focusing on poxvirus maturation.

Protein Monkeypox Virus D13L Protein (MPXV D13L)
Protein Synonym D13L; OPG105; MPXVgp107; Rifampicin-resistance protein; Viral scaffold protein D13

Shipping and Storage

This product is shipped with gel ice bags. Avoid repeated freezing and thawing. Store for 12 months at -20°C or -80°C.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

  1. Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.
Inquiry Basket